 | • レポートコード：C-GIR20G2804 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「ヤヌスキナーゼ（JAK）阻害剤の世界市場2019年」は、グローバルにおけるヤヌスキナーゼ（JAK）阻害剤市場を展望するレポートです。ヤヌスキナーゼ（JAK）阻害剤のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・ヤヌスキナーゼ（JAK）阻害剤の市場概観 ・ヤヌスキナーゼ（JAK）阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ヤヌスキナーゼ（JAK）阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・ヤヌスキナーゼ（JAK）阻害剤の世界市場規模 ・ヤヌスキナーゼ（JAK）阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・ヤヌスキナーゼ（JAK）阻害剤のアメリカ市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のカナダ市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のメキシコ市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ヤヌスキナーゼ（JAK）阻害剤のドイツ市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のイギリス市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のロシア市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ヤヌスキナーゼ（JAK）阻害剤の日本市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤の中国市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤の韓国市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤のインド市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤の東南アジア市場規模推移 ・ヤヌスキナーゼ（JAK）阻害剤の南米市場分析（ブラジル、アルゼンチン等） ・ヤヌスキナーゼ（JAK）阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ヤヌスキナーゼ（JAK）阻害剤の種類別分析/販売量、売上、市場シェア（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリチチニブ、ペフィシチニブ） ・ヤヌスキナーゼ（JAK）阻害剤の用途別分析/市場規模（自己免疫疾患、腫瘍学） ・ヤヌスキナーゼ（JAK）阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ヤヌスキナーゼ（JAK）阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Janus Kinase (JAK) Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Janus Kinase (JAK) Inhibitors.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Janus Kinase (JAK) Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Janus Kinase (JAK) Inhibitors market by product type and applications/end industries.
Market Segment by Companies, this report covers
Astellas Pharma, Inc.
Novartis AG
Eli Lilly and Co.
Incyte Corp.
Pfizer Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ruxolitinib
Tofacitinib
Oclacitinib
Baricitinib
Peficitinib
Market Segment by Applications, can be divided into
Autoimmune Disorders
Oncology
Table of Contents
1 Janus Kinase (JAK) Inhibitors Market Overview
1.1 Product Overview and Scope of Janus Kinase (JAK) Inhibitors
1.2 Classification of Janus Kinase (JAK) Inhibitors by Types
1.2.1 Global Janus Kinase (JAK) Inhibitors Revenue Comparison by Types (2019-2024)
1.2.2 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Types in 2018
1.2.3 Ruxolitinib
1.2.4 Tofacitinib
1.2.5 Oclacitinib
1.2.6 Baricitinib
1.2.7 Peficitinib
1.3 Global Janus Kinase (JAK) Inhibitors Market by Application
1.3.1 Global Janus Kinase (JAK) Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Autoimmune Disorders
1.3.3 Oncology
1.4 Global Janus Kinase (JAK) Inhibitors Market by Regions
1.4.1 Global Janus Kinase (JAK) Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Janus Kinase (JAK) Inhibitors Status and Prospect (2014-2024)
1.5 Global Market Size of Janus Kinase (JAK) Inhibitors (2014-2024)
2 Company Profiles
2.1 Astellas Pharma, Inc.
2.1.1 Business Overview
2.1.2 Janus Kinase (JAK) Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Janus Kinase (JAK) Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly and Co.
2.3.1 Business Overview
2.3.2 Janus Kinase (JAK) Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.4 Incyte Corp.
2.4.1 Business Overview
2.4.2 Janus Kinase (JAK) Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer Inc.
2.5.1 Business Overview
2.5.2 Janus Kinase (JAK) Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
3 Global Janus Kinase (JAK) Inhibitors Market Competition, by Players
3.1 Global Janus Kinase (JAK) Inhibitors Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Janus Kinase (JAK) Inhibitors Players Market Share
3.2.2 Top 10 Janus Kinase (JAK) Inhibitors Players Market Share
3.3 Market Competition Trend
4 Global Janus Kinase (JAK) Inhibitors Market Size by Regions
4.1 Global Janus Kinase (JAK) Inhibitors Revenue and Market Share by Regions
4.2 North America Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
4.3 Europe Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
4.5 South America Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
5 North America Janus Kinase (JAK) Inhibitors Revenue by Countries
5.1 North America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
5.2 USA Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
5.3 Canada Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
5.4 Mexico Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
6 Europe Janus Kinase (JAK) Inhibitors Revenue by Countries
6.1 Europe Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
6.2 Germany Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
6.3 UK Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
6.4 France Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
6.5 Russia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
6.6 Italy Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Countries
7.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
7.2 China Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
7.3 Japan Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
7.4 Korea Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
7.5 India Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
8 South America Janus Kinase (JAK) Inhibitors Revenue by Countries
8.1 South America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
8.2 Brazil Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
8.3 Argentina Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
8.4 Colombia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Janus Kinase (JAK) Inhibitors by Countries
9.1 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
9.2 Saudi Arabia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
9.3 UAE Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
9.4 Egypt Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
9.5 Nigeria Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
9.6 South Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
10 Global Janus Kinase (JAK) Inhibitors Market Segment by Type
10.1 Global Janus Kinase (JAK) Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Global Janus Kinase (JAK) Inhibitors Market Forecast by Type (2019-2024)
10.3 Ruxolitinib Revenue Growth Rate (2014-2024)
10.4 Tofacitinib Revenue Growth Rate (2014-2024)
10.5 Oclacitinib Revenue Growth Rate (2014-2024)
10.6 Baricitinib Revenue Growth Rate (2014-2024)
10.7 Peficitinib Revenue Growth Rate (2014-2024)
11 Global Janus Kinase (JAK) Inhibitors Market Segment by Application
11.1 Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2014-2019)
11.2 Janus Kinase (JAK) Inhibitors Market Forecast by Application (2019-2024)
11.3 Autoimmune Disorders Revenue Growth (2014-2019)
11.4 Oncology Revenue Growth (2014-2019)
12 Global Janus Kinase (JAK) Inhibitors Market Size Forecast (2019-2024)
12.1 Global Janus Kinase (JAK) Inhibitors Market Size Forecast (2019-2024)
12.2 Global Janus Kinase (JAK) Inhibitors Market Forecast by Regions (2019-2024)
12.3 North America Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
12.4 Europe Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
12.6 South America Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Janus Kinase (JAK) Inhibitors Picture
Table Product Specifications of Janus Kinase (JAK) Inhibitors
Table Global Janus Kinase (JAK) Inhibitors and Revenue (Million USD) Market Split by Product Type
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Types in 2018
Figure Ruxolitinib Picture
Figure Tofacitinib Picture
Figure Oclacitinib Picture
Figure Baricitinib Picture
Figure Peficitinib Picture
Table Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Application (2014-2024)
Figure Janus Kinase (JAK) Inhibitors Revenue Market Share by Applications in 2018
Figure Autoimmune Disorders Picture
Figure Oncology Picture
Table Global Market Janus Kinase (JAK) Inhibitors Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Table Astellas Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Type and Applications
Table Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Janus Kinase (JAK) Inhibitors Type and Applications
Table Novartis AG Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Co. Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Type and Applications
Table Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Incyte Corp. Basic Information, Manufacturing Base and Competitors
Table Incyte Corp. Janus Kinase (JAK) Inhibitors Type and Applications
Table Incyte Corp. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Janus Kinase (JAK) Inhibitors Type and Applications
Table Pfizer Inc. Janus Kinase (JAK) Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Players (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue Share by Players (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Share by Players in 2017
Figure Global Janus Kinase (JAK) Inhibitors Revenue Share by Players in 2018
Figure Global Top 5 Players Janus Kinase (JAK) Inhibitors Revenue Market Share in 2018
Figure Global Top 10 Players Janus Kinase (JAK) Inhibitors Revenue Market Share in 2018
Figure Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Regions (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Regions in 2018
Figure North America Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure South America Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Table North America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
Table North America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure USA Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Canada Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Mexico Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure UK Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure France Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Russia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Italy Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure China Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Japan Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Korea Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure India Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Table South America Janus Kinase (JAK) Inhibitors Revenue by Countries (2014-2019)
Table South America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Argentina Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Colombia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure UAE Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Egypt Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure Nigeria Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Figure South Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) by Type (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue Share by Type (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Share by Type (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Share by Type in 2018
Table Global Janus Kinase (JAK) Inhibitors Revenue Forecast by Type (2019-2024)
Figure Global Janus Kinase (JAK) Inhibitors Market Share Forecast by Type (2019-2024)
Figure Global Ruxolitinib Revenue Growth Rate (2014-2019)
Figure Global Tofacitinib Revenue Growth Rate (2014-2019)
Figure Global Oclacitinib Revenue Growth Rate (2014-2019)
Figure Global Baricitinib Revenue Growth Rate (2014-2019)
Figure Global Peficitinib Revenue Growth Rate (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue by Application (2014-2019)
Table Global Janus Kinase (JAK) Inhibitors Revenue Share by Application (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Share by Application (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Share by Application in 2018
Table Global Janus Kinase (JAK) Inhibitors Revenue Forecast by Application (2019-2024)
Figure Global Janus Kinase (JAK) Inhibitors Market Share Forecast by Application (2019-2024)
Figure Global Autoimmune Disorders Revenue Growth Rate (2014-2019)
Figure Global Oncology Revenue Growth Rate (2014-2019)
Figure Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Janus Kinase (JAK) Inhibitors Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Janus Kinase (JAK) Inhibitors Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
Figure Europe Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
Figure South America Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue Market Forecast (2019-2024)
プロテインキナーゼ阻害剤市場：世界及び中国市場分析・予測（～2024年） Protein Kinase Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Protein Kinase Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Protein Kinase Inh…- 未分化リンパ腫キナーゼ阻害剤の世界市場 2019年版：種類別（クリゾチニブ、セリチニブ、塩酸アレクチニブ）、用途別（NSCLC、乳がん、大腸がん、神経芽細胞腫、卵巣がん、その他） Scope of the Report: The worldwide market for Anaplastic Lymphoma Kinase Inhibitors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the A…
- 二重特異性分裂促進因子活性化タンパク質キナーゼ(MAPK)市場：世界及び中国市場分析・予測（～2024年） Dual Specificity Mitogen Activated Protein Kinase Kinase 1 Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Dual Specificity Mitogen Activated Protein Kinase Kinase 1 industry with a focus on the Chinese market. The report prov…
- オーロラキナーゼA市場：世界及び中国市場分析・予測（～2024年） Aurora Kinase A Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Aurora Kinase A industry with a focus on the Chinese market. The report provides key statistics on the market status of the Aurora Kinase A manufacturers and is a…
- チロシンプロテインキナーゼFYN市場：世界及び中国市場分析・予測（～2024年） Tyrosine Protein Kinase Fyn Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Tyrosine Protein Kinase Fyn industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tyrosine Prote…